IllumiNeuro Protocol
Four-Peptide Cognitive Enhancement Blend
Blend of four nootropic peptides for cognitive enhancement: Pinealon (pineal bioregulator), PE-22-28 (neuritogenic), NA-Selank Amidate (anxiolytic/cognitive), and NA-Semax Amidate (neuroprotective/cognitive). The standard formulation totals 48mg — Pinealon 10mg, PE-22-28 10mg, NA-Selank 8mg, NA-Semax 20mg. Multiple neurological pathways are covered at once, giving comprehensive cognitive support; no clinical studies cover this four-peptide combination specifically.
Overview
Blend of four nootropic peptides for cognitive enhancement: Pinealon (pineal bioregulator), PE-22-28 (neuritogenic), NA-Selank Amidate (anxiolytic/cognitive), and NA-Semax Amidate (neuroprotective/cognitive). The standard formulation totals 48mg — Pinealon 10mg, PE-22-28 10mg, NA-Selank 8mg, NA-Semax 20mg. Multiple neurological pathways are covered at once, giving comprehensive cognitive support; no clinical studies cover this four-peptide combination specifically.
Four peptides, each with a neurological mechanism of its own. Modulation of sphingosine-1-phosphate receptors is how PE-22-28 drives neurite outgrowth and connectivity between neurons. Pinealon is a bioregulator; pineal gland function and circadian regulation are what it supports. Upregulation of BDNF, and neuroprotection with it, come from NA-Semax Amidate. NA-Selank Amidate is the anxiolytic, working through GABA modulation and through immune-neuroendocrine regulation. Neural regeneration, mood support, neuroprotection, cognitive enhancement — that is the theoretical reach of the four together.
Research indications
What the compound has been studied for, grouped by body system. Effect size is the reported magnitude where it was measured — not a recommendation.
BDNF support alongside neuritogenic effects may improve memory formation and learning.
Sustained attention and mental clarity are supported by the NA-Semax component.
Neural tissue is protected from oxidative stress and damage along multiple pathways.
Anxiolytic effects come from NA-Selank via GABA modulation.
Stress resilience is helped by immune-neuroendocrine support.
Overall mood may improve on the combined neurotransmitter-system effects.
Neural connectivity and neurite extension are promoted by PE-22-28.
Pineal function is supported by Pinealon, as are healthy sleep-wake cycles.
- Class
- Fixed-ratio peptide combination
- Research status
- Limited research
- Typical dose
- 100–500 µg total blend daily
- Frequency
- Once daily, typically morning
- Cycle length
- 4–8 weeks
- Storage
- Lyophilized: Room temperature. Reconstituted: 2-8°C, use within 4 weeks
Molecular data
- Type
- Fixed-ratio peptide combination
Dosing reference
Doses reported in the literature and by suppliers. These are a record of what has been used in research — reference, never instruction.
| Context | Route | Amount | Frequency |
|---|---|---|---|
| Conservative cognitive support | SubQ or intranasal | 100-200mcg total blend | Once daily (morning) |
| Standard protocol | SubQ | 200-400mcg total blend | Once daily |
| Enhanced protocol | SubQ | 400-500mcg total blend | Once daily |
| Intranasal cognitive | Intranasal spray | 100-300mcg | Once or twice daily |
Interactions
NA-Semax is already in the blend; adding more risks overdosing.
NA-Selank is already present; no more should be added.
Pinealon is already included.
Pineal and longevity support that complements; mechanisms differ.
Each is highly neuroactive; combining multiple cognitive enhancers calls for caution.
Targets differ; BPC-157 may add healing and gut-brain effects.
Cognitive effects of the blend are stimulatory; monitoring is warranted alongside other stimulants.
What to expect
Safety
Mechanistic flags — properties of the pathway, not observed adverse events.
- Mild headache initially
- Nasal irritation where the route is intranasal
- Vivid dreams possible — a Pinealon effect
- Mild reactions where injected
- Severe headaches
- Significant mood changes
- Allergic reactions
- Cognition impaired rather than enhanced
- Pregnancy or breastfeeding
- The four-peptide combination has no clinical trials
- Bipolar disorder or psychosis — cognitive enhancers warrant caution
- Seizure disorders, as a theoretical concern
Quality checklist
What to confirm before trusting a batch of research material. A verification aid — not an endorsement of any supplier.
- Third-party Certificate of AnalysisIndependent lab · dated · lot-matched.
- HPLC purity ≥ 98%Reverse-phase trace included.
- Mass-spec identity confirmedMALDI-TOF or ESI-MS.
- Counterion stated (acetate ≫ TFA)TFA salts can confound bioassays.
- Endotoxin / sterility statementRelevant once reconstituted.
- Lyophilised · cold-chain shippedStored −20 °C, shipped on ice.
- Labelled “research use only”No therapeutic or dosing claims.
Recorded signals for this compound · 9
- ✓Reputable research supplier
- ✓All four components confirmed by third-party testing
- ✓Ratios verified on the certificate of analysis
- ✓Shipped with a proper cold chain
- !Batch variability is possible in a complex four-peptide formulation
- !Status is research-only, with no approval for human use
- ×No Certificate of Analysis
- ×Suspiciously low pricing
- ×Component ratios cannot be verified
FAQ
Are IllumiNeuro's components taken separately, or only as the blend?
Individual components can be taken on their own, but extra NA-Semax or NA-Selank must not go on top of the blend — both are already in it. The standard 48 mg vial holds all four at fixed ratios: PE-22-28 10 mg, Pinealon 10 mg, NA-Semax 20 mg, NA-Selank 8 mg.
Is IllumiNeuro effective for anxiety in particular?
Anxiolytic effects of the NA-Selank component are documented, the route being GABA modulation. No clinical studies cover the four-peptide combination, though. Research on the individual peptides shows promise in anxiety, while human efficacy data remain limited.
Morning or evening for an IllumiNeuro injection?
Morning is the preferred timing where the aim is cognitive benefit through the day. Evening has an argument in Pinealon's sleep-supporting properties, but most users report better focus and mental clarity on a morning dose taken on an empty stomach.